Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

489
In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
489
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

295
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
295
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

82
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
82
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

2.0K
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
2.0K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

International consensus on dose reduction of biologics for patients with psoriasis: The DR. Delphi study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

Active surveillance in older adults with basal cell carcinoma: A survey amongst European dermatologists.

Journal of the European Academy of Dermatology and Venereology : JEADV·2025
Same author

Belgian recommendations for managing psoriasis in a changing treatment landscape.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

Value in psoriasis (IRIS) trial: implementing value-based healthcare in psoriasis management - a 1-year prospective clinical study to evaluate feasibility and value creation.

BMJ open·2023
Same author

Initiating value-based healthcare in psoriasis: Proposing a value-based outcome set for daily clinical practice.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Health state utility instruments in patients with keratinocyte cancer and actinic keratosis: a cross-sectional study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022

相关实验视频

Updated: Jul 19, 2025

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
02:28

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

430

确定牛皮患者的价值概况

N T Hilhorst1,2, E Abatih3, E Deprez1,2

  • 1Dermatology Research Unit, Ghent University, Ghent, Belgium.

Experimental dermatology
|August 11, 2023
PubMed
概括
此摘要是机器生成的。

这项研究确定了三种不同的牛皮患者的患者价值概况,使医疗保健专业人员能够为更好的结果和价值量身定制治疗. 这些配置文件有助于指导牛皮的管理,以更有目标的方法.

关键词:
结果就是结果.牛皮是一种牛皮.价值的价值的价值是一个价值.

更多相关视频

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.0K
Lymphocyte Isolation from Human Skin for Phenotypic Analysis and Ex Vivo Cell Culture
10:31

Lymphocyte Isolation from Human Skin for Phenotypic Analysis and Ex Vivo Cell Culture

Published on: April 8, 2016

14.6K

相关实验视频

Last Updated: Jul 19, 2025

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
02:28

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

430
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.0K
Lymphocyte Isolation from Human Skin for Phenotypic Analysis and Ex Vivo Cell Culture
10:31

Lymphocyte Isolation from Human Skin for Phenotypic Analysis and Ex Vivo Cell Culture

Published on: April 8, 2016

14.6K

科学领域:

  • 皮肤病学 皮肤病学
  • 卫生经济学 卫生经济学
  • 患者报告的结果

背景情况:

  • 医疗保健专业人员 (HCP) 旨在最大限度地提高患者价值,定义为与成本相对的健康结果.
  • 鉴定牛皮的个体患者相关结果仍然是一个挑战.

研究的目的:

  • 在牛皮队伍中定义不同的"患者价值配置文件".
  • 为了使这些个人资料能够转化为日常实践,以提高个体患者的价值.

主要方法:

  • 用主要成分 (HCPC) 的等级聚类来分组具有相似结果排名的患者.
  • 开发了一个多类决策树 (MDT),使用社会人口统计和临床数据将患者分配到已识别的集群中.

主要成果:

  • 120名牛皮患者参加了这项研究;中位数年龄为50岁,36.7%为女性,中位数PASI为2.4,中位数疾病持续时间为17年.
  • 确定了三个不同的患者价值概况:生活质量 (QoL),成本和治疗.
  • 开发的MDT在将患者分配到这些个人资料时实现了64%的准确性.

结论:

  • 在牛皮队列中发现了三种不同的患者价值概况.
  • 一个MDT促进了容易的患者分配到这些配置文件.
  • 医务人员可以利用这些配置文件来个性化牛皮的管理,以实现更有目标的方法.